ARNUITY ELLIPTA
ARNUITY ELLIPTA
Approved
DIN Number
02446588
Drug Class
Human
Market Date
Dec 14, 2015
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02446588
AIG Number0152271003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA09 FLUTICASONE FUROATE
Product Specifications
Dosage FormPowder
Route of AdministrationInhalation
,
Oral
AHFS Classification52:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLUTICASONE FUROATEActive
Strength: 200 MCG / ACT
Monograph: FLUTICASONE FUROATE